Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2022

Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2017-2028)
2.2 Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
3.5 Molecular Diagnostics Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.2.5 BD Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Detail
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.3.5 bioMérieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Siemens AG
11.6.1 Siemens AG Company Detail
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens AG Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen NV
11.10.1 Qiagen NV Company Detail
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen NV Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Development
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Detail
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.13.5 GenMark Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Bacterial Infectious Disease Testing
Table 3. Key Players of Viral Infectious Disease Testing
Table 4. Key Players of Parasitic Infectious Disease Testing
Table 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2017-2022)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2023-2028)
Table 11. Molecular Diagnostics Infectious Disease Testing Market Trends
Table 12. Molecular Diagnostics Infectious Disease Testing Market Drivers
Table 13. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 14. Molecular Diagnostics Infectious Disease Testing Market Restraints
Table 15. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players (2017-2022)
Table 17. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2021)
Table 18. Ranking of Global Top Molecular Diagnostics Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2017-2022)
Table 26. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2023-2028)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2017-2022)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2023-2028)
Table 32. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Abbott Laboratories Company Detail
Table 43. Abbott Laboratories Business Overview
Table 44. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product
Table 45. Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 46. Abbott Laboratories Recent Development
Table 47. BD Company Detail
Table 48. BD Business Overview
Table 49. BD Molecular Diagnostics Infectious Disease Testing Product
Table 50. BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 51. BD Recent Development
Table 52. bioMérieux Company Detail
Table 53. bioMérieux Business Overview
Table 54. bioMérieux Molecular Diagnostics Infectious Disease Testing Product
Table 55. bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 56. bioMérieux Recent Development
Table 57. Thermo Fisher Scientific Company Detail
Table 58. Thermo Fisher Scientific Business Overview
Table 59. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product
Table 60. Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 61. Thermo Fisher Scientific Recent Development
Table 62. F. Hoffmann-La Roche Company Detail
Table 63. F. Hoffmann-La Roche Business Overview
Table 64. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product
Table 65. F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 66. F. Hoffmann-La Roche Recent Development
Table 67. Siemens AG Company Detail
Table 68. Siemens AG Business Overview
Table 69. Siemens AG Molecular Diagnostics Infectious Disease Testing Product
Table 70. Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 71. Siemens AG Recent Development
Table 72. Veridex Company Detail
Table 73. Veridex Business Overview
Table 74. Veridex Molecular Diagnostics Infectious Disease Testing Product
Table 75. Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 76. Veridex Recent Development
Table 77. Luminex Company Detail
Table 78. Luminex Business Overview
Table 79. Luminex Molecular Diagnostics Infectious Disease Testing Product
Table 80. Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 81. Luminex Recent Development
Table 82. GenMark Diagnostics Company Detail
Table 83. GenMark Diagnostics Business Overview
Table 84. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 85. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 86. GenMark Diagnostics Recent Development
Table 87. Qiagen NV Company Detail
Table 88. Qiagen NV Business Overview
Table 89. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product
Table 90. Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 91. Qiagen NV Recent Development
Table 92. Genomix Biotech Company Detail
Table 93. Genomix Biotech Business Overview
Table 94. Genomix Biotech Molecular Diagnostics Infectious Disease TestingProduct
Table 95. Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 96. Genomix Biotech Recent Development
Table 97. BioTheranostics Company Detail
Table 98. BioTheranostics Business Overview
Table 99. BioTheranostics Molecular Diagnostics Infectious Disease TestingProduct
Table 100. BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 101. BioTheranostics Recent Development
Table 102. GenMark Diagnostics Company Detail
Table 103. GenMark Diagnostics Business Overview
Table 104. GenMark Diagnostics Molecular Diagnostics Infectious Disease TestingProduct
Table 105. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 106. GenMark Diagnostics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type: 2021 VS 2028
Figure 2. Bacterial Infectious Disease Testing Features
Figure 3. Viral Infectious Disease Testing Features
Figure 4. Parasitic Infectious Disease Testing Features
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Laboratory Research Case Studies
Figure 8. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 9. Global Molecular Diagnostics Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Molecular Diagnostics Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region: 2021 VS 2028
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players in 2021
Figure 13. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
Figure 15. North America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 17. United States Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 21. Germany Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Region (2017-2028)
Figure 29. China Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 37. Mexico Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 41. Turkey Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 44. BD Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 45. bioMérieux Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 48. Siemens AG Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 49. Veridex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 50. Luminex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 51. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 52. Qiagen NV Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 53. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 54. BioTheranostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 55. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs